Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, April 19, 2014
Technology Networks
 
Register | Sign in
Home Page>Latest Webcasts

  Webcasts

Scientific News
Drug Does Not Improve Set of Cardiovascular Outcomes for Diastolic Heart Failure
NIH-supported study finds drug does appear to reduce hospitalizations for diastolic heart failure.
Entirely Novel Strategy to Molecular Anticancer Therapy Tricks Malignant Cells
New drug prevents tumour growth by inhibiting the nucleotide sanitizing enzyme MTH1.
New Trial of Personalized Cancer Treatment Begins in Oxford
Phase I trial in Oxford will investigate a new drug, called CXD101.
Flow Microreactor Synthesis in Organo-Fluorine Chemistry
This review focuses on successful examples on synthesis and reactions of fluorine-containing molecules by the use of flow microreactor systems.
Reviewing Colchicaceae Alkaloids - Perspectives of Evolution on Medicinal Chemistry
Researchers have shown how thinking about evolution can influence selection of plant material in drug lead discovery.
New Drug Treatment Reduces Chronic Pain Following Shingles
New drug EMA401 reduce pain and did not cause any serious side effects.
Scripps' Scientists Develop Promising Drug Candidates for Pain and Addiction
Two new drug scaffolds offer researchers novel tools that act on the kappa opioid receptor.
World’s Tiniest Drug Cabinets could be Attached to Cancerous Cells for Long Term Treatment
Reservoirs of pharmaceuticals could be manufactured to bind specifically to infected tissue such as cancer cells for slow, concentrated delivery of drug treatments.
Malaria Drug Target Raises Hopes for New Treatments
Scientists identify way to stop malaria parasites from multiplying.
Tobacco, Drug Use in Pregnancy Can Double Risk of Stillbirth
NIH network study documents elevated risk associated with marijuana, other substances.

Cationic Lipid Formulations with Programmed Biodegradability for Gene Therapy Applications
Asier Unciti-Broceta, Senior Research Fellow, University of Edinburgh, speaking at MedChem Europe

Novel Histamine Receptor Family Antagonists by Fragment Screening and Molecular Modelling
Mark Slack, Group Leader Cellular Assays, Evotec, speaking at MedChem Europe

The Development of Synthetic Approaches that Allow the Systematic Exploration of Chemical Space
Adam Nelson, Professor, University of Leeds, speaking at MedChem Europe

Next-Generation Kinase Inhibitors following a Retro-Design Approach
Gerhard Mueller, Chief Scientific Officer, Proteros Fragments, speaking at MedChem Europe

Beyond Growing and Linking - Impact of Fragments on the Discovery of Kinase Inhibitors
Andreas Kuglstatter, Research Scientist II, Hoffmann-La Roche, speaking at MedChem Europe

A Novel Platform Technology Sheds Light on the Molecular Mechanisms of Liver Toxicity of Two Parkinson Drugs
Friedrich Kroll, Head of Medicinal Chemistry, Caprotec, speaking at MedChem Europe

The Impact of Fragment Optimization on Lead Quality
György Keseru, Head of Discovery Chemistry, Gedeon Richter, speaking at MedChem Europe

Chemogenomic Strategies to Expand the Bioactive Chemical Space
Edgar Jacoby, Group Leader, Novartis, speaking at MedChem Europe

Dynamic Combinatorial Library – an Integrated Approach for Direct Lead Discovery Using Chemical Fragments
Beining Chen, Senior Lecturer, University of Sheffield, speaking at MedChem Europe

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 125
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv